Oncotelic's Cancer Research Breakthrough: Biomarkers' Role in HCC and PDAC
December 15, 2025 — Oncotelic Therapeutics publishes peer-reviewed study on biomarkers in liver and pancreatic cancers, analyzing data from 7,000+ patients to advance personalized oncology treatments.